Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07712042
What this trial is testing

Tafolecimab in Hyperlipidemia: A Study of Different Dosing Intervals

Who this might be right for
Hyperlipidemia
Mei Gao 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT05553834
What this trial is testing

PCSK9 Inhibitor and PD-1 Inhibitor in Patients With Metastatic, Refractory To Prior Anti PD-1 Non-small Cell Lung

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Duke University 60
Post-approval studies (Phase 4)Study completedNCT06431763
What this trial is testing

Investigate LDL-cholesterol Lowering With Inclisiran Compared to Bempedoic Acid in Patients With Atherosclerotic Cardiovascular Disease.

Who this might be right for
Hypercholesterolemia
Novartis Pharmaceuticals 402
Testing effectiveness (Phase 2)Study completedNCT03193047
What this trial is testing

Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180mg When Added to PCSK9 Inhibitor Therapy

Who this might be right for
Hypercholesterolemia
Esperion Therapeutics, Inc. 59
Very early researchActive Not RecruitingNCT04862260
What this trial is testing

Cholesterol Disruption in Combination With the Standard of Care in Patients With Advanced Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Ductal AdenocarcinomaPancreatic CancerPancreas Cancer+1 more
CHU de Quebec-Universite Laval 3
Not applicableNot Yet RecruitingNCT06854523
What this trial is testing

Assessing Coronary Non-Culprit Plaque Early with Start of PCSK9 Inhibitors in Acute Myocardial Infarction (ACCESS-AMI)

Who this might be right for
Acute Myocardial Infarction
Yun Dai Chen 300
Post-approval studies (Phase 4)Not Yet RecruitingNCT07803679
What this trial is testing

A Trial Assessing the Effectiveness of Evolocumab in Reducing the Plaque Burden in Participants With Subclinical Atheroma

Who this might be right for
Coronary Artery DiseaseHypercholesterolemiaAtheroma+1 more
Amgen 308
Testing effectiveness (Phase 2)UnknownNCT04338165
What this trial is testing

Impact of PCSK9 Inhibitors on Coronary Microvascular Dysfunction in Patients With Atherosclerotic Cardiovascular Disease Proved by Myocardial Ischemia and Needing Coronarography

Who this might be right for
Atherosclerotic Cardiovascular Disease
University Hospital, Grenoble 66
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07621562
What this trial is testing

Tafolecimab Combined With Sintilimab and SOX in the Treatment of pMMR/MSS Gastric Cancer

Who this might be right for
Gastric AdenocarcinomaEsophagogastric Juction CancerProficient Mismatch Repair
First Affiliated Hospital of Zhejiang University 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07391722
What this trial is testing

DNV001 Injection in Patients With Hypercholesterolemia

Who this might be right for
Primary Hypercholesterolemia
Hangzhou Dinovate Biotech Co., Ltd 120
Large-scale testing (Phase 3)Not Yet RecruitingNCT07775339
What this trial is testing

Long-Term Efficacy and Safety of Lerodalcibep in Children and Adolescents With Familial Hypercholesterolemia

Who this might be right for
Heterozygous Familial Hypercholesterolemia (HeFH)
LIB Therapeutics LLC 150
Large-scale testing (Phase 3)Looking for participantsNCT06568471
What this trial is testing

A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia

Who this might be right for
HypercholesterolemiaDyslipidemiasPrimary Hypercholesterolemia+4 more
Hasten Biopharmaceutical Co., Ltd. 210
Large-scale testing (Phase 3)Ended earlyNCT02524106
What this trial is testing

Bococizumab HIV Evaluation (B-HIVE) Study

Who this might be right for
DyslipidemiaCardiovascular Disease
University of California, San Francisco 11
Large-scale testing (Phase 3)Study completedNCT05004675
What this trial is testing

Trial to Evaluate Efficacy and Safety of LIB003 and Inclisiran in High-risk CVD Patients

Who this might be right for
HypercholesterolemiaAtherosclerotic Ischemic Disease
LIB Therapeutics LLC 166
Not applicableUnknownNCT04730648
What this trial is testing

Acute Myocardial Infarction and Unstable Angina Patients With PCSK9 Inhibitor Usage Study

Who this might be right for
Lipid MetabolismCardiovascular Diseases
Shenzhen People's Hospital 100
Not applicableStudy completedNCT05184530
What this trial is testing

In-hospital Initiation of PCSK9 Inhibitor in Patients With Acute Myocardial Infarction

Who this might be right for
Coronary Disease
First Affiliated Hospital Xi'an Jiaotong University 7,556
Post-approval studies (Phase 4)UnknownNCT04100434
What this trial is testing

Effect of Evolocumab Added to Moderate-Intensity Statin Therapy on LDL-C Lowering and Cardiovascular Adverse Events in Patients With Acute Coronary Syndrome

Who this might be right for
Acute Coronary SyndromeProprotein Convertase Subtilisin/Kexin Type 9 Inhibitor
Tianjin Chest Hospital 500
Not applicableLooking for participantsNCT07540741
What this trial is testing

Efficacy and Safety of PCSK9 Inhibitors in Patients With Large-Artery Atherosclerosis (LAA) Ischemic Stroke

Who this might be right for
Acute Ischemic Stroke
First Affiliated Hospital of Harbin Medical University 1,000
Large-scale testing (Phase 3)UnknownNCT03634293
What this trial is testing

Treatment of Severe Infection With Antihyperlipidemia Drug

Who this might be right for
SepsisSeptic Shock
Wolfson Medical Center 712
Testing effectiveness (Phase 2)UnknownNCT04101643
What this trial is testing

PCSK9 Inhibitor Treatment for Patients With SPG5

Who this might be right for
Hereditary Spastic Paraplegia Type 5
First Affiliated Hospital of Fujian Medical University 30
Next Page